| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008298070 |
| P356 | DOI | 10.1023/A:1005470702369 |
| P698 | PubMed publication ID | 9870209 |
| P2093 | author name string | M A Vilaseca | |
| M Pineda | |||
| R Artuch | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Prooxidant effects of antioxidant vitamins. Introduction | Q28280104 | ||
| Exogenous coenzyme Q (coq) fails to increase coq in skeletal muscle of two patients with mitochondrial myopathies | Q28335432 | ||
| Biochemical, physiological and medical aspects of ubiquinone function | Q34298940 | ||
| Therapy of mitochondrial disorders | Q39598522 | ||
| Treatment of mitochondrial disease | Q40898218 | ||
| Primary and secondary carnitine deficiency syndromes. | Q40954913 | ||
| The treatment of congenital lactic acidoses | Q41180888 | ||
| Automated analysis for free and short-chain acylcarnitine in plasma with a centrifugal analyzer | Q44872302 | ||
| Deficiency of subunits of Complex I and mitochondrial encephalomyopathy | Q48107157 | ||
| A mitochondrial myopathy with a defective respiratory chain and carnitine deficiency | Q48751673 | ||
| Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease | Q57043469 | ||
| Successful treatment of pure myopathy, associated with complex I deficiency, with riboflavin and carnitine | Q67984500 | ||
| 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies | Q68150271 | ||
| Benign mitochondrial myopathy with deficiency of NADH-CoQ reductase and cytochrome c oxidase | Q70162893 | ||
| Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy | Q70552833 | ||
| Determination of lactate, pyruvate, beta-hydroxybutyrate and acetoacetate with a centrifugal analyser | Q70862863 | ||
| Vitamin E in a mitochondrial myopathy with proliferating mitochondria | Q72225726 | ||
| Oxidative phosphorylation diseases and mitochondrial DNA mutations: diagnosis and treatment | Q72770227 | ||
| Biochemical and molecular investigations in respiratory chain deficiencies | Q72792351 | ||
| Tocopherol in inborn errors of intermediary metabolism | Q73563221 | ||
| P433 | issue | 8 | |
| P921 | main subject | mitochondrial disease | Q935710 |
| P304 | page(s) | 837-845 | |
| P577 | publication date | 1998-12-01 | |
| P1433 | published in | Journal of Inherited Metabolic Disease | Q6295359 |
| P1476 | title | Biochemical monitoring of the treatment in paediatric patients with mitochondrial disease | |
| P478 | volume | 21 |
| Q37210464 | Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society |
| Q45012788 | Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases |
| Q73701269 | Mitochondrial Disease |
| Q39573813 | Mitochondrial disease patients' perception of dietary supplements' use. |
| Q82029875 | Mitochondrial encephalomyopathies |
| Q40221471 | Nutrition Therapy for Mitochondrial Neurogastrointestinal Encephalopathy with Homozygous Mutation of the TYMP Gene |
| Q47988632 | Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems. |
| Q73179201 | Oxygen consumption measurement in lymphocytes for the diagnosis of pediatric patients with oxidative phosphorylation diseases |
| Q74243285 | [Congenital errors of metabolism: cause of oxidative stress?] |
Search more.